INTRODUCTION 23
Dyspnea, or perceived breathlessness, is a symptom commonly reported by individuals with 24 obstructive lung diseases such as asthma and chronic obstructive lung disease (COPD) 1, 2 . The 25 prevalence of dyspnea ranges from 9% in the general population 3 to approximately 50% in 26 individuals with COPD 4-7 . These estimates may be low, as dyspnea is often underreported or not 27 recognized by clinicians 8 . Dyspnea is related to a number of outcomes, including general health 28 9 , health related quality of life 10, 11 , hospital admissions, and mortality 12 among individuals with 29 COPD and asthma. In fact in patients with COPD, dyspnea has been shown to be a better 30 predictor of mortality than airway obstruction as measured by the percentage of predicted forced 31 expiratory volume in one second (FEV1) 13 . In other words, the severity of breathlessness cannot 32 simply be predicted by disease severity or lung function measures. Research indicates that the 33 improvement in dyspnea from participation in pulmonary rehabilitation occurs despite a lack of 34 concurrent improvements in FEV1 14 . This association between dyspnea and physical inactivity is 35 well-established, such that lower physical activity levels are related to worse dyspnea 15, 16 . 36
Several other factors may influence perceptions of dyspnea. Recently, Ekström et al. 37 found that female sex, smoking, presence of asthma, and chronic bronchitis were correlates of 38 dyspnea in healthy adults 3 . FEV1, body mass index, anxiety, and depression have also been 39 identified as correlates of resting dyspnea in adults with asthma or COPD [17] [18] [19] . Psychological 40 factors such as mood or anxiety disorders may have particular significance given their increased 41 prevalence among adults with COPD 20 . However, limited work has been done at the population-42 level to identify potential predictors of resting and exertional dyspnea among individuals with an 43 existing obstructive lung disease. This is critical, as simple interventions targeting dyspnea may 44 have a significant impact on the quality of life of individuals with obstructive lung diseases. 45 3 Thus, the purpose of this study was to use population-level data from the Canadian Longitudinal 46 Study on Aging (CLSA) to identify potential correlates of resting and exertional dyspnea. Given 47 that perceived dyspnea is known to differ by sex, analyses were conducted separately for males 48 and females. 49
METHODS 50
Data Source and Participants: The CLSA is a nationally representative, stratified, random 51 sample of 51,338 Canadian females and males aged 45 to 85 years (at baseline). The purpose of 52 this survey is to collect data on the health and quality of life of Canadians to better understand 53 the processes and dimensions of aging. Data for the present study are from participants 54 (n=30,097) in the Comprehensive sample which collected data through questionnaires, physical 55 examinations, and biological samples. 56 Inclusion in the CLSA was limited to those who were able to read and speak either 57 French or English. Residents in the three territories and some remote regions, persons living on 58 federal First Nations reserves and other First Nations settlements in the provinces, and full-time 59 members of the Canadian Armed Forces were excluded. Individuals living in long-term care 60 institutions (i.e., those providing 24-hour nursing care) were excluded at baseline; however, 61 those living in households and transitional housing arrangements (e.g., seniors' residences, in 62 which only minimal care is provided) were included. Finally, those with a cognitive impairment 63 at the time of recruitment were excluded. 64
Only those with complete data for dyspnea outcomes (n=29,670), sociodemographic 65 variables, selected health conditions, and physical activity (n=18,232) were included in the 66 analysis. Only those who had self reported asthma and/or COPD, and did not report lung cancer 67 4 were included (n=2,854). Of these, 2,064 had asthma only, 514 had COPD only, and 276 had 68 both asthma and COPD. 69
Self reported COPD and asthma were determined based on the questions "Has a doctor 70 told you that you have/had any of the following: emphysema, chronic bronchitis, chronic 71 obstructive pulmonary disease (COPD), or chronic changes in lungs due to smoking?" and "Has 72 a doctor ever told you that you have asthma?". Self report was used rather than spirometry to 73 classify COPD because 24% of participants with self-reported COPD had taken short and/or long 74 acting bronchodilators prior to spirometry. 75
Measures 76

Dyspnea Variables 77
Participants were asked the following four questions relating to resting and exertional dyspnea: 78 "Do you become short of breath walking on flat surfaces?", "Do you become short of breath 79 climbing stairs or walking up a small hill?", "Have you had an attack of shortness of breath that 80 came on following strenuous activity at any time within the last 12 months?", and "Have you had 81 an attack of shortness of breath that came on during the day when you were at rest at any time 82 within the last 12 months?". Response options to each question were "Yes" or "No". Each 83 dichotomous variable was treated as an outcome in our analyses. 84
Health and Health Behaviour Variables 85
Chronic Conditions: Participants were asked to report chronic conditions that had been 86 diagnosed by a physician and that were expected to last, or had already lasted, 6 months or more. 87
We chose to use variables pertaining to anxiety disorder, mood disorder, and cardiovascular 88 disease due to their known associations with breathlessness 18, 19, 21 . Anxiety disorder and mood 89 disorder were based on the questions "Has a doctor ever told you that you have an anxiety 90 5 disorder such as a phobia, obsessive-compulsive disorder or a panic disorder?" and "Has a doctor 91 ever told you that you have a mood disorder such as depression (including manic depression), 92 bipolar disorder, mania, or dysthymia?". Participants were classified as having cardiovascular 93 disease if they responded positively to either of the following two questions: "Has a doctor ever 94 told you that you have heart disease (including congestive heart failure, or CHF)?" or "Has a 95 doctor ever told you that you have peripheral vascular disease or poor circulation in your 96 limbs?". 97
Physical Activity and Functional Fitness: Participants completed a timed up and go (TUG) 98 assessment which required them to stand up from a chair with arm rests, walk 3 metres, turn 99 around, walk back, and sit down. The time for participants to complete the TUG was used as a 100 global indicator of physical function. To better understand the impact of exertional dyspnea, we 101 also used responses from the question "In the past 12 months, have you felt like you wanted to 102 participate more in physical activities? If yes, what prevented you from doing physical 103 activities/more physical activities?". Three response options were selected for the current 104 analysis: "Injury/Illness", "Health condition limitation", and "Lack of energy" due to their 105 applicability to individuals with obstructive lung conditions. 106
Others: For smoking history, participants were categorized as Never smoked, <10 pack years, or 107 10 packs years or more based on responses to questions pertaining to the number of cigarettes 108 smoked per day and total years smoked (further detail provided elsewhere 22 ). 109
Height was measured to the nearest 0.1 cm by trained professionals (Seca 213). Body fat 110 percentage was measured using bioimpedance (Hologic Discovery A Dual Energy X-Ray 111 Absorptiometry). Total body fat percentage was assessed with participants lying flat on their 112 back with their arms at their side and feet pointed in. 113 6 A handheld spirometer was used (TruFlow Easy-On) to assess lung function. Only those 114 with major contraindications did not perform the test 23 . Maximal inspiratory and expiratory 115 maneuvers were performed to obtain FEV1. Further detail on the procedures can be found in the 116 CLSA spirometry standard operating procedures 23 . Only those who were able to complete three 117 acceptable maximal maneuvers were included; that is, the difference between the best two FEV1 118 and Forced vital capacity values was within 150ml. Participants with extreme data outside of 119 normal physiological limits were also excluded (i.e. FEV1 >10 Litres). The best FEV1 was used 120 for analysis. Percent predicted FEV1 was calculated based on age, height, ethnicity, and sex, 121 using formulas developed by the Global Lung Function Initiative 24 . Absolute FEV1 was used in 122 analyses rather than percent predicted FEV1 due to previous research indicating that absolute 123 values of lung function explain differences in breathlessness 25 , and because age, sex, and height 124 were already included in each logistic regression. 125
Sociodemographic Variables 126
Participants were asked to report their age and sex, and provided information on household 127 income. For household income, responses were categorized as "Less than $20,000", "$20,000 to 128 $49,999", "$50,000 to $99,999", "$100,000 to $149,999", and "$150,000 or more". 129
Statistical Analysis 130
Means and frequencies were used to describe the sample. Odds ratios were calculated for each of 131 the dyspnea outcomes (at rest, walking on a flat surface, climbing stairs or walking uphill, and 132 following strenuous activity) using logistic regressions. Each of the health and health behaviour 133 (anxiety disorder, mood disorder, heart disease, TUG time, injury/illness limiting PA, health 134 condition limiting PA, lack of energy limiting PA, smoking history, height, body fat percentage, 135 and FEV1), and sociodemographic (age and household income) variables were included in the 136 same models. Analyses were conducted separately for males and females 3 . 137
All analyses were performed using SPSS v.24. To ensure national representation and to 138 compensate for under-represented groups, sampling weights were applied to regression models. 139
Significance was set at p<0.05. Additional details on sampling, methods and weighting on the 140 CLSA can be found in the protocol document 26, 27 . 141
RESULTS 142
The sample had a mean age of 61.3 ± 9.8 years and was 60.0% female. Females had a 143 significantly higher body fat percentage, were shorter, had a lower FEV1, and a higher percent 144 predicted FEV1 (Table 1 ). More females also reported shortness of breath at rest, walking on flat 145 surface, and walking uphill/climbing stairs than males. Additional sample characteristics can be 146 found in Table 1 . 147
For all logistical regressions, OR presented are from models where all variables were entered 148 simultaneously, thus these findings are independent of lung function, height, age, and other 149 correlates. 150
Significant associations in the sample of males are highlighted in Figure 1 . Having a mood 151 disorder was associated with higher odds of reporting dyspnea at rest, while walking on a flat 152 surface, and following strenuous activity when compared to males without a mood disorder. A 153 one litre higher FEV1 was associated with approximately half the odds of reporting dyspnea for 154 three of four dyspnea outcomes. 155
Significant associations in the sample of females are highlighted in Figure 2 . Females with an 156 anxiety disorder were more likely to report dyspnea while walking on a flat surface, and 157 following strenuous exercise compared to those without an anxiety disorder. A slower TUG time 158 8 was also associated with higher odds of reporting dyspnea for all three exertional dyspnea 159 outcomes. 160
DISCUSSION 161
Using data from the CLSA, we sought to identify correlates of resting and exertional dyspnea 162 among middle-aged and older Canadian males and females with an obstructive lung disease. The 163 three main findings of this study are 1) females with an anxiety disorder and males with a mood 164 disorder have higher odds of reporting dyspnea, independent of lung function and other 165 correlates, 2) functional fitness may be important for limiting dyspnea, as individuals, 166 particularly females, with a slower TUG time were more likely to report dyspnea, 3) age, body 167 fat percentage, and FEV1 are important correlates of dyspnea among both males and females. 168
These findings are the first to use population level data to identify potential correlates of dyspnea 169 in adults with asthma and COPD, and have implications for future research and interventions 170 targeting dyspnea. 171
Health and Health Behaviours 172
Chronic Conditions: With regards to the chronic condition variables assessed, we found that 173 having a mood disorder, anxiety disorder, or cardiovascular disease was associated with a higher 174 odds of reporting dyspnea, even after adjusting for the effects of lung function, body fat %, and 175 other correlates. 176
Previous research on the association between dyspnea and anxiety or depressive 177 symptoms is mixed among individuals with COPD. Most studies demonstrate an association 18, 178 28, 29 ; however, some do not 30 . It has been suggested that the stress of having a chronic condition 179 may be related to the increased likelihood of having an anxiety or mood disorder 31 . For anxiety 180 disorders in particular, the hyperventilation model has been suggested, whereby anxiety results in 181 9 baseline hyperventilation, which when added to obstruction and hypocapnia can aggravate 182 symptoms of dyspnea 32 . Patients with anxiety may also be more likely to misinterpret symptoms 183 of mild dyspnea as more severe 32 . Further, highly anxiety sensitive individuals appear to be 184 more sensitive to the anticipation of a hyperventilation procedure 33 . Therefore, the anticipation 185 of dyspnea may lead to a greater perception of dyspnea among individuals with both anxiety and 186 an obstructive lung disease. 187
We observed sex-differences in the associations with anxiety and mood disorders. The 188 reason for these sex differences is unclear. It has been suggested that males and females with 189 major depression present with different symptoms 34 . Females also have higher rates of both 190 depression and anxiety 35 . The differences observed in the current study may relate to the 191 subjective experience of how males and females experience dyspnea. Males with mood disorders 192 may be more likely to experience dyspnea, whereas females may experience different symptoms. 193
In our study, the prevalence of anxiety was similar between males and females, but mood 194 disorders were more prevalent in females compared to males (26 vs. 17%). This may help to 195 explain sex differences observed in mood disorder. Understanding these associations is critical, 196 as depression and anxiety are often untreated in adults with COPD 36 . Thus, proper treatment of 197 anxiety and mood disorders may be aid in improving sensations of dyspnea, and thus quality of 198
life. 199
The presence of heart disease was associated with dyspnea in females, such that having 200 heart disease was associated with higher odds of reporting dyspnea at rest and while walking 201 uphill 3 . However, among males, only dyspnea at rest was associated with heart disease, and this 202 association was in the opposite direction expected. It is possible that the variable we used was 203 not appropriate as it included any heart disease, including congestive heart failure. Future 204 10 research using specific cardiovascular disease variables may help us understand the interactive 205 effects of cardiopulmonary disease on dyspnea. 206 Physical Activity and Functional Fitness: Reporting factors (Injury/Illness, Health condition 207 limitation, and Lack of energy) that limited participation in physical activity, or having a slower 208 TUG time, were both associated with reporting dyspnea. Among males, reporting a lack of 209 energy that prevented more participation in physical activity was associated with dyspnea while 210 walking on a flat surface and while walking uphill/climbing stairs. This is not surprising, as 211 fatigue, or lack or energy, is a common symptom among those with COPD, and has been shown 212 to be correlated with dyspnea, 37-39 . 213
Among females, TUG time, injury/illness, and reporting a health limitation that prevented 214 more participation in physical activity were the most consistently associated with resting and 215 exertional dyspnea. TUG time may be an important modifiable correlate of dyspnea as the 216 presence of dyspnea may lead to avoidance of physical activity, causing further deconditioning, 217 and thus worsening of dyspnea. Self-reported functional fitness has been shown to be associated 218 with dyspnea in adults with COPD 37, 40 41 . Pulmonary rehabilitation programs have also led to 219 improvements in 6 minute walk distance, and dyspnea 14, 42, 43 . Thus, measures of functional 220 fitness may be useful clinical tools for physicians to use to better understand dyspnea in their 221
patients. 222
Others: Our finding that body fat percentage was associated with exertional dyspnea outcomes is 223 consistent with previous literature that indicates that fat free mass index is correlated with 224 dyspnea among COPD patients 44 , and that body mass index has is associated with dyspnea 225 among adults 40 years and older 3, 4, 45 . It is important to note that higher levels of exertional 226 dyspnea among individuals with more body fat may be related to reduced lung volumes and 227 11 greater work of breathing required 45 ; however, body mass index is often lower in individuals 228 with the most severe COPD, (GOLD stages 3 and 4) 46 . Clearly, body fat is not the only factor 229 leading to an increased perception of dyspnea, but it may be a contributing factor. 230
An interesting sex-difference emerged on the association of FEV1 and dyspnea outcomes. 231
Dyspnea at rest was significantly associated with FEV1 among females, but not among males. 232
Females may be more prone to reporting dyspnea at rest than males due to smaller airways, and 233 smaller lung volumes 47, 48 . In fact, in our sample, only 71 of 1,139 males (6.2%) reported 234 dyspnea at rest. For all exertional dyspnea outcomes, a lower FEV1 was significantly associated 235 with a higher odds of reporting dyspnea (after adjustment for age and height). FEV1 has 236 consistently been shown to be negatively associated with dyspnea among the general population 237 3, 4 , individuals with asthma 11 , and with severe COPD 49 . Despite these associations, the 238 relevance of this is unclear as even in the absence of lung function improvements following 239 pulmonary rehabilitation, improvements in dyspnea have been observed 14 . 240
Sociodemographic Correlates 241
Our finding that older age was associated with lower dyspnea was of interest. Increasing age is 242 associated with a decline in lung function 24 and some studies from the general population 243 indicate that increasing age is associated with an increase in severity or prevalence of dyspnea 6, 244 7 . However, there is evidence to suggest that increasing age is associated with a decrease in the 245 occurrence of dyspnea 4 . This supports the notion that individuals can become accustomed, and 246 therefore desensitised to feelings of breathlessness. In fact, researchers have suggested a decrease 247 in the perception of bronchoconstriction in response to methacholine in older adults with and 248 without asthma 50 . Furthermore, it is possible that individuals with dyspnea are less likely to 249 survive to old age, leaving an older population that is "healthier" and less likely to report 250 dyspnea (survivor bias) 6 . This emphasizes the importance of treating dyspnea seriously in 251 individuals of all ages. 252
Our finding that household income was only significant for two of the dyspnea outcomes 253 among females, and with none of the outcomes among males was somewhat surprising. Previous 254 research indicates that higher household income and lower social disadvantage is associated with 255 lower perceived dyspnea 45, 51 . However, these studies assessed dyspnea using the mMRC, and 256
Bowden et al. used social disadvantage based on geographical area rather than household 257 income. Importantly, socioeconomic status of the sample used for the current study was high, 258
with 72.1% of participants reporting a household income greater than $50,000. Thus, future 259 research in a more diverse sample may be warranted. 260
Strengths and Limitations 261
Strengths of this study include the large representative sample, and the objectively measured 262 lung function and body composition measures. There are also a number of limitation to the 263 present study. First, the questions related to dyspnea for the CLSA have not been used in other 264 research studies so direct comparisons can not be performed. The CLSA has performed a 265 validation study for the broader set of chronic airflow obstruction questions and spirometry, 266 regarding the ability to detect asthma or COPD 52 . Second, while we did remove those with lung 267 cancer, we did not adjust for additional chronic conditions. Thus, care should be taken when 268 interpreting the findings, as other chronic conditions may impact perceptions of dyspnea. Third, 269 participants in the present study had fairly mild obstruction (86.9 ± 17.3 and 89.0 ± 16.6 percent 270 of predicted FEV1 for males and females, respectively), possibly due to the inclusion of 271 individuals who may have well controlled asthma. However, this emphasizes that the perception 272 of dyspnea in this sample was not only due to poor lung function. Finally, it is important to note 273 13 that data from the CLSA are cross-sectional, thus, reverse-causality cannot be ruled out at this 274 time. 275
CONCLUSION 276
In conclusion, using data from a large Canadian sample of older adults with obstructive lung 277 disease, we found that those with an anxiety or mood disorder, and those with lower functional 278 fitness had higher odds of reporting dyspnea after adjusting for lung function and other important 279 correlates. These findings have implications for clinical practice as they could aid in early 280 identification of adults at increased risk of dyspnea and poor health outcomes. This study also 281 provides a basis for future research exploring the role of functional fitness and physical activity 282 in improving perceptions of dyspnea among those with existing obstructive lung disease. 283
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